Clinical trial
An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated…
NCT00092898 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092898 |
|---|---|
| Title | An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to An Ongoing Regimen of Ezetimibe 10 mg in Patients Homozygous Sitosterolemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lipid Metabolism, Inborn Errors, Heart Disease |
| Intervention type | Drug |
| Interventions | MK0653, ezetimibe, Comparator: placebo |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: